UFGD develops detergent that eliminates the larvae of the dengue mosquito

aedes aegypti mosquitoes

A group of researchers from the Federal University of Grande Dourados, coordinated by Professor Dr. Alexeia Barufatti, are developing a detergent made from the liquid of the cashew nutshell, which in contact with water, eliminates the dengue mosquito larvae. This research is funded by PPSUS through Fundect.

According to Alexeia, the group’s work began in 2015 when the first experiments were carried out with the liquid extracted during the roasting of the cashew nut. The research group is formed by students of scientific initiation, master’s, doctorate, post-doctoral students, in addition to professors from UFGD, UFMS, and UNIFESP.

According to the biologist and postdoctoral fellow at UFGD, Bruno Amaral Crispim, the idea is that the compound is used as a normal detergent in domestic activities and that it would indirectly fulfill the objective of eliminating the larvae of the Aedes Aegypti mosquito.

From the cashew nut oil, we made chemical changes that made this product a detergent, which after tests of the larvicidal effect, proved its effectiveness in combating mosquito larvae. We also carry out tests of environmental effect where we verify that this product when reaching rivers and streams presents little or no toxicity in non-target organisms such as algae, fish, and crustaceans.

cashew nut oil

According to Bruno, the next steps in the project are safety tests for human health and afterward, after the product’s total effectiveness has been proven, make the companies that produce detergents “buy the idea” and start using this compound in their products. products.

ACD RNAscope ISH-IHC

ACD RNAscope ISH-IHC

2 wishes to satisfy
Transcriptomics & Proteomics

  • It can simultaneously detect the expression of RNA and Protein in a single cell in the same sample, and retain tissue morphological information.
  • Overcoming the problems of low sensitivity and low specificity of traditional ISH, RNAscope has the advantages of high sensitivity, high specificity, time-saving and easy operation, allowing RNAscope ISH-IHC to get better results
  • Can be applied to: Immuno-oncology, Neurobiology, Cell, Gene Therapy & IHC Validation

Three precautions before implementing Dual ISH-IHC/IF

  • Confirm that RNAscope ISH can get good results
  • Confirm that antibodies can get good results in IHC/IF
  • Since the pre-processing of RNAscope will use Protease, it is recommended to use Protease for pre-processing before testing IHC/IF experiments to confirm antibodies and proteins The binding position will not be affected, the IHC/IF signal has not weakened, and the background value has not increased (as shown below).

RNAscope Duplex + IHC

RNAscope VS Duplex combined with IHC to detect the expression of immune cells chemokines and cytokines in human lung tumors

(A) Detect the RNA of IL-12 and CXCL9 and the macrophage Marker CD68 protein
(B) Detect the RNA of TGFB and FOXP3 and the T cell Marker CD4 protein.

RNAscope HIplex + IHC

Dual ISH-IHC/IF can detect different neuronal subtypes and detect the expression of circRNA splice variants in specific cells.

RNAscope HiPlex can detect up to 12 target RNAs; the figure simultaneously detects the performance of Drd1 + and Drd2 + striatal neuron subtypes, neuron Marker NeuN protein (white) and circRNA splice variants.

SiRNA & shRNA Gene Silencers

SiRNA & shRNA Gene Silencers

RNAi (RNA interference): The combination of small fragments of nucleotide molecules with complementary mRNAs leads to degradation of the mRNA and gene knockdown. The Santa Cruz RNAi system includes siRNA, shRNA Plasmid and shRNA Lentiviral particles. The product line covers more than 99% mouse and human protein-coding genes.

● siRNA gene silencers
consist of three to five pairs of 19-25nt (nucleotide), and the concentration of 10µM can provide 50-100 transfections

● shRNA plasmid DNA
uses Hi promote to make shRNA stable and continuous performance. With puromycin resistant, antibiotics can be used for screening

● shRNA Lentiviral particles
use viral infection to enter cells

Common Q&A

Q1: What are the main differences between shRNA Lentiviral Particles and shRNA Plasmids?
A1: shRNA Lentiviral Particles use viral infection to enter cells. It is recommended to use primary cells that are not easy to transfect.

Q2: Are the siRNA and shRNA sequences identical?
A2: Yes

Q3: How to confirm the effect of transfection?
A3: The transfection or transduction efficiency can be confirmed by the green fluorescence of copGFP plasmid (sc-108083) and copGFP Lentiviral Particles (sc-108084)

Q4: What is the difference between the shRNA plasmid item number (h) and (h2)?
A4: (h) and (h2) are used to silence the same gene, but the sequence is different.

Q5: Can you provide the sequence of siRNA or shRNA?
A5: Yes, just provide the batch number after ordering!

Q6: Can lentiviral vector plasmid be amplified by itself?
A6: No

Q7:shRNA contains 3-5 plastids? Can they be purchased separately?
A7: The original factory currently only provides siRNA sequences for purchase separately

Rotary cell culture system (RCCS)

Rotary cell culture system (RCCS)

RCCS is a unique bioreactor technology that produces 3D cultures based on the principle of clinorotation, which is defined as the abolition of gravitational force by slow rotation around one or two axes.

RCCS is a dynamic system that suspends cells without mechanical damage and allows cells to easily aggregate into a 3D spheroid with a sufficient supply of nutrients and oxygen. RCCS can also be used for co-cultivation of several types of cell cultures, cells can be cultured with or without the use of various scaffolds.

It is the first bioreactor system designed to simultaneously integrate the ability to co-cultivate cells and features low shear (and consequently low turbulence) and high nutrient transfer to cells. Together, these properties promote spheroid formation and cell proliferation in three-dimensional spheroids.

Two types of bioreactors: disposable 3D bioreactors and autoclavable 3D bioreactors